Publications by authors named "Albert Enz"

19Publications

Decahydroisoquinoline derivatives as novel non-peptidic, potent and subtype-selective somatostatin sst(3) receptor antagonists.

Bioorg Med Chem Lett 2010 Mar 21;20(5):1728-34. Epub 2010 Jan 21.

Novartis Institutes for BioMedical Research, Global Discovery Chemistry-Neuroscience, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
March 2010

Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.

Bioorg Med Chem Lett 2009 Mar 7;19(5):1287-91. Epub 2009 Feb 7.

Novartis Institutes for Biomedical Research, Neuroscience Disease Area, 4002 Basel, Switzerland.

View Article and Find Full Text PDF
March 2009

Ergoline derivatives as highly potent and selective antagonists at the somatostatin sst 1 receptor.

Bioorg Med Chem Lett 2008 Feb 26;18(3):979-82. Epub 2007 Dec 26.

Neuroscience Chemistry, Novartis Institutes for BioMedical Research, WSJ-088.3.06, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
February 2008

Targeting acetylcholinesterase and butyrylcholinesterase in dementia.

Int J Neuropsychopharmacol 2006 Feb 5;9(1):101-24. Epub 2005 Aug 5.

Novartis Neuroscience, Novartis Pharmaceuticals Corporation, NJ, USA.

View Article and Find Full Text PDF
February 2006

Cholinesterases: roles in the brain during health and disease.

Curr Alzheimer Res 2005 Jul;2(3):307-18

Department of Biomedical Sciences, Wolfson Centre for Age-related Diseases, Hodgkin Building, Guy's Campus, King's College, London, SE1 1UL, UK.

View Article and Find Full Text PDF
July 2005

Rivastigmine as a modulator of the neuronal glutamate transporter rEAAC1 mRNA expression.

Dement Geriatr Cogn Disord 2005 21;19(1):18-23. Epub 2004 Sep 21.

Department of Neuroscience and Locomotion, Division of Geriatric Medicine, Linkopings Universitet Hospital, SE-581 85 Linkoping, Sweden.

View Article and Find Full Text PDF
May 2005

Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain.

Neuropharmacology 2004 Sep;47(3):408-13

Neuroscience Disease Area, Department of Neuroscience, Novartis Institutes for Biomedical Research, WSJ-386.762, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
September 2004